Actively Recruiting
Study of Medtronic Hugo Robotic Surgery System for Prostatectomy in an Outpatient Surgical Center
Led by Central Ohio Urology Group · Updated on 2026-10-15
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of the Medtronic Hugo Robotic Assisted Surgery RAS System in prostate cancer patients undergoing prostatectomy procedures at an ambulatory surgical center ASC. This observational study aims to collect data on clinical outcomes, procedural efficiency, patient recovery, and economic factors. The goal is to fill current knowledge gaps and show how robotic surgery may be feasible and beneficial in this outpatient setting. The study observes patients undergoing radical prostatectomy using the Hugo RAS System at the Central Ohio Urology Group. It gathers detailed clinical and operational data during surgeries performed in the ASC setting. This includes measuring complications during and after surgery, as well as any need to switch to another surgical method. The study does not assign treatments but records outcomes from the standard use of the robotic system. Participants will be monitored from the start of surgery through 90 days afterward to track perioperative and postoperative complications. Data collected will include clinical outcomes and economic measures related to the surgery and recovery. The study lasts from the surgery date through a 90-day follow-up period, providing insights into patient recovery and procedure effectiveness in this ambulatory care environment.
CONDITIONS
Brief Title
Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here